Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting Among Patients Attending a Referral Hospital in Southern Highland Tanzania

Overview

Journal Adv Pharmacol Pharm Sci

Publisher Wiley

Date 2023 May 18

PMID 37200768

Authors

Nathanael Sirili

Manase Kilonzi

Dorkasi L Mwakawanga

Juma A Mohamedi

Joseph Matobo Thobias

Aurelia Clement

Davance Mwasomola

Stella E Mushy

Affiliations

Soon will be listed here.

Abstract

Purpose: This study assessed the awareness, actions, and predictors of actions on adverse drug reaction reporting among patients attending a referral hospital in southern highland Tanzania.

Methods: A hospital-based cross-sectional study was conducted from January to August 2022 at Mbeya Zonal Referral Hospital (MZRH) in Mbeya, Tanzania. A total of 792 adult patients with chronic conditions attending outpatient clinics at MZRH were recruited consecutively. A semistructured questionnaire was used to collect demographic characteristics, ADR awareness, and actions when encountering ADR. Data were analyzed using the statistical package for social sciences (SPSS) version 23 and results are summarized using frequency and percentages. Binary logistic regression was used to assess the predictors associated with reporting ADR among patients. value ≤0.05 was considered statistically significant.

Results: Out of 792, 397 (50.1%) were males and 383 (48.6%) had a primary education level. Only 171 (21.6%) participants previously experienced ADR, and 111 (14.1%) were aware that ADR is an unexpected harm that occurs after medication use. The majority 597 (70.3%) of the participants said will report ADR to healthcare providers, 706 (88.9%) prefer reporting ADR to healthcare providers, and 558 (69.1%) said patients are not aware of the importance of reporting ADR. Patients aged below 65 years of age, unemployed ((AOR (95% CI) = 0.4 (0.18-0.87), self-employed ((AOR (95% CI) = 0.5 (0.32-0.83)), and those who ever encountered ADR ((AOR (95% CI) = 0.1 (0.05-0.11)) were more likely to report the ADR to HCPs compared to the rest.

Conclusions: The majority of patients are not aware of what is ADR and the importance of ADR reporting. Most of the patients prefer to report ADR to healthcare providers. We recommend an awareness campaign to raise awareness of the patients on ADR and other methods of ADR reporting.

Citing Articles

Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania.

Sirili N, Kilonzi M, Mwakawanga D, Mohamedi J, Thobias J, Clement A Adv Pharmacol Pharm Sci. 2023; 2023:7761649.

PMID: 37200768 PMC: 10188260. DOI: 10.1155/2023/7761649.

References

Sahu R, Yadav R, Prasad P, Roy A, Chandrakar S . Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. Springerplus. 2014; 3:695. PMC: 4258196. DOI: 10.1186/2193-1801-3-695. View

Sirili N, Kilonzi M, Mwakawanga D, Mohamedi J, Thobias J, Clement A . Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania. Adv Pharmacol Pharm Sci. 2023; 2023:7761649. PMC: 10188260. DOI: 10.1155/2023/7761649. View

van Grootheest K, de Jong-van den Berg L . Patients' role in reporting adverse drug reactions. Expert Opin Drug Saf. 2004; 3(4):363-8. DOI: 10.1517/14740338.3.4.363. View

Asiamah M, Akuffo K, Nortey P, Donkor N, Danso-Appiah A . Spontaneous reporting of adverse drug reaction among health professionals in Ghana. Arch Public Health. 2022; 80(1):33. PMC: 8772084. DOI: 10.1186/s13690-021-00783-1. View

Harmark L, van Grootheest A . Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol. 2008; 64(8):743-52. DOI: 10.1007/s00228-008-0475-9. View

Narumol J, Arunrot P, Krska J . Survey of patients' experiences and their certainty of suspected adverse drug reactions. Int J Clin Pharm. 2015; 37(1):168-74. DOI: 10.1007/s11096-014-0060-5. View

Inacio P, Cavaco A, Airaksinen M . The value of patient reporting to the pharmacovigilance system: a systematic review. Br J Clin Pharmacol. 2016; 83(2):227-246. PMC: 5237689. DOI: 10.1111/bcp.13098. View

Hariraj V, Aziz Z . Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report. Ther Innov Regul Sci. 2018; 52(6):757-763. DOI: 10.1177/2168479017745025. View

Valinciute-Jankauskiene A, Kubiliene L . Adverse Drug Reaction Reporting by Patients in 12 European Countries. Int J Environ Res Public Health. 2021; 18(4). PMC: 7915689. DOI: 10.3390/ijerph18041507. View

10.

Osanlou R, Walker L, Hughes D, Burnside G, Pirmohamed M . Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open. 2022; 12(7):e055551. PMC: 9255409. DOI: 10.1136/bmjopen-2021-055551. View

11.

Gyllensten H, Hakkarainen K, Hagg S, Carlsten A, Petzold M, Rehnberg C . Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults. PLoS One. 2014; 9(3):e92061. PMC: 3956863. DOI: 10.1371/journal.pone.0092061. View

12.

Adisa R, Omitogun T . Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019; 19(1):926. PMC: 6889459. DOI: 10.1186/s12913-019-4775-9. View

13.

Sabblah G, Seaneke S, Kushitor M, van Hunsel F, Taxis K, Duwiejua M . Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approach. PLoS One. 2022; 17(3):e0264699. PMC: 8893697. DOI: 10.1371/journal.pone.0264699. View

14.

Martin K, Begaud B, Latry P, Miremont-Salame G, Fourrier A, Moore N . Differences between clinical trials and postmarketing use. Br J Clin Pharmacol. 2003; 57(1):86-92. PMC: 1884419. DOI: 10.1046/j.1365-2125.2003.01953.x. View

15.

. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972; 498:1-25. View

16.

Vilhelmsson A . Consumer Narratives in ADR Reporting: An Important Aspect of Public Health? Experiences from Reports to a Swedish Consumer Organization. Front Public Health. 2015; 3:211. PMC: 4556027. DOI: 10.3389/fpubh.2015.00211. View

17.

Lopez-Gonzalez E, Herdeiro M, Figueiras A . Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009; 32(1):19-31. DOI: 10.2165/00002018-200932010-00002. View

18.

Paola K, Claudio G . The value of direct patient reporting in pharmacovigilance. Ther Adv Drug Saf. 2022; 11:2042098620940164. PMC: 8842177. DOI: 10.1177/2042098620940164. View

19.

Kitisopee T, Assanee J, Sorofman B, Watcharadmrongkun S . Consumers' adverse drug event reporting via community pharmacists: three stakeholder perception. J Pharm Policy Pract. 2022; 15(1):19. PMC: 8919562. DOI: 10.1186/s40545-022-00417-z. View

20.

Weigmann K . Consumer reporting of adverse drug reactions: Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care. EMBO Rep. 2016; 17(7):949-52. PMC: 4931570. DOI: 10.15252/embr.201642616. View